Apollomics (APLM) Total Current Liabilities (2021 - 2025)
Apollomics (APLM) reported Total Current Liabilities of $6.3 million for Q4 2025, down 55.25% quarter-over-quarter from $14.1 million in Q2 2023.
Apollomics (APLM) Total Current Liabilities (2021 - 2025) Analysis & Trends
Apollomics (APLM) has 4 years of Total Current Liabilities data on file, last reported at $6.3 million in Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $6.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $6.3 million (changed N/A YoY), and the FY2025 annual result was $6.3 million, changed N/A from the prior year.
- Total Current Liabilities slipped to $6.3 million in Q4 2025 per APLM's latest filing, from $14.1 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $14.1 million in Q2 2023 and troughed at $6.3 million in Q4 2025.
- A 4-year average of $11.6 million and a median of $13.0 million in 2021 frame the typical range for Total Current Liabilities.
- On a YoY basis, Total Current Liabilities climbed as much as 8.84% in 2022 and fell as far as 8.84% in 2022.
- A 4-year view of Total Current Liabilities shows it stood at $13.6 million in 2021, then slipped by 8.84% to $12.4 million in 2022, then gained by 14.4% to $14.1 million in 2023, then slumped by 55.25% to $6.3 million in 2025.
- Business Quant data shows APLM's Total Current Liabilities at $6.3 million in Q4 2025, $14.1 million in Q2 2023, and $12.4 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 72.86 Mn |
| 10 | Apollomics | 294.00 Mn | 294.00 Mn | - | 6.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.33 Mn |
| Jun 30, 2023 | 14.14 Mn |
| Dec 31, 2022 | 12.36 Mn |
| Dec 31, 2021 | 13.56 Mn |